235 related articles for article (PubMed ID: 8614712)
1. [High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience].
Gava A; Fontan L; Bolner A; Botturi M; Cafaro I; Di Marco A; Marazzato G; Muto P; Orecchia R; Orsatti M; Parisi SS; Rigon A
Radiol Med; 1996; 91(1-2):118-21. PubMed ID: 8614712
[TBL] [Abstract][Full Text] [Related]
2. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
[TBL] [Abstract][Full Text] [Related]
3. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
[TBL] [Abstract][Full Text] [Related]
4. [High-dose-rate brachytherapy. The indications, technic and preliminary results].
Orecchia R; Ragona R; Anglesio S; Tessa M; Del Mastro E; Sannazzari GL
Minerva Med; 1996; 87(1-2):1-7. PubMed ID: 8610019
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
6. Intraluminal high dose rate brachytherapy combined with external radiotherapy in the treatment of oesophageal cancer.
Barone D; Coccia G; Marziano C; Tricerri R; Bonelli L; Tomassini E; Bistolfi F
Panminerva Med; 1993 Jun; 35(2):86-92. PubMed ID: 8414629
[TBL] [Abstract][Full Text] [Related]
7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
8. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].
Patonay P; Naszály A; Mayer A
Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114
[TBL] [Abstract][Full Text] [Related]
9. [External irradiation combined with intracavitary brachytherapy for esophageal cancer].
Zhou G; Chen G; Cui S; Sun J; Yang D
Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):925-7. PubMed ID: 16201172
[TBL] [Abstract][Full Text] [Related]
10. Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer.
Skowronek J; Piotrowski T; Zwierzchowski G
Brachytherapy; 2004; 3(2):87-94. PubMed ID: 15374540
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
[TBL] [Abstract][Full Text] [Related]
12. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
[TBL] [Abstract][Full Text] [Related]
13. [Intracavitary brachytherapy in esophageal neoplasms. Experience at the Radiology Institute of Brescia].
La Face B; Micheletti E; Baroncelli G; Catalano G; Huscher A; Cestari R; Ravelli P; Verzelletti L; Galelli M
Radiol Med; 1997 May; 93(5):607-12. PubMed ID: 9280947
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
[TBL] [Abstract][Full Text] [Related]
15. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
16. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
Greene FL; Boulware RJ; Bianco J
Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986
[TBL] [Abstract][Full Text] [Related]
17. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
18. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
19. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
20. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.
Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD;
Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
